Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Alcaine - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Alcaine

Approved

STANDARD

Alcaine

Alcon Research, LLC🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 6e671e3e93f202f7
Company: Alcon Research, LLC
Type: Standard

Approval Details

Approval Id: 6e671e3e93f202f7
Drug Approval Philippines Name: Alcaine
Product Name: Alcaine
Registration Number: DR-XY13591
Brand Name: Alcaine
Generic Name: Proparacaine Hydrochloride
Dosage Form: Sterile Ophthalmic Solution
Dosage Strength: 5mg/mL (0.5%)
Manufacturer: Alcon Research, LLC
Importer: Alcon Laboratories (Phils.), Inc.
Company Detail Path: /organization/alcon-research-llc
Issuance Date: 04 October 2022
Expiry Date: 04 October 2027
Pharmacologic Category: Local Anesthetic
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

6e671e3e93f202f7

Type

Standard

Back to Philippines FDA Approvals